A Comparison of Pentosan Polysulphate (SP54) and Heparin I: Mechanism of Action on Blood Coagulation

Summary

The effects of SP54 on inhibition of thrombin, factor Xa and factor IXa, in the presence and absence of antithrombin III (At III), have been examined and compared to those of heparin. SP54 potentiated inhibition of thrombin and Xa by purified At III, but crossed immunoelectrophoresis data indicated that these effects were mediated by binding to the enzyme, rather than to At III. Relatively high concentrations of SP54 were required for inhibition of thrombin and Xa in plasma, but at concentrations less than 2 μg/ml there was a marked suppression of the intrinsic activation of factor X. This effect was shown to be independent of At III, and to be due largely to inhibition of factor IXa. Prothrombin activation by factor Xa and phospholipid was also suppressed by SP54 in the absence of At III, and its effect on the APTT was also shown to be independent of At III. It is concluded that at relatively low concentrations the anticoagulant actions of SP54 are mainly due to these At III-independent pathways.

Key words

Heparin - Pentosan polysulphate - SP54 - Mechanism in vitro

• References

• 1 Soria C, Soria J, Ryckewaert JJ, Holme E, Caen JP. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin. Thromb Res 1980; 19: 455-463
• 2 Joffe S. Drug prevention of postoperative deep vein thrombosis. A comparative study of calcium heparinate and sodium pentosan polysulfate. Arch Surg 1976; 111: 37-40
• 3 Bergqvist D, Ljungner H. Prevention of deep vein thrombosis (DVT) in abdominal surgery. A prospective comparison between sodium pentosan polysulphate and dextran 70. Thromb Haemostas 1981; 46: 93 (Abstr).
• 4 Czapek EE, Kwaan HC, Szczecinski M. The effect of a sulfated polysaccharide on antithrombin III. J Lab Clin Med 1980; 95: 783-790
• 5 Vinazzer H, Haas S, Stemberger A. Influence on the clotting mechanism of sodium pentosan polysulphate (SP54) in comparison to commercial beef lung sodium heparin. Thromb Res 1980; 20: 57-68
• 6 Miller-Andersson M, Gaffney PJ. Preparation and stability of a highly purified human thrombin standard. Thromb Res 1980; 20: 109-122
• 7 Benamon-Djjane D, Josso F, Soulier JP. Purification de la prothrombine humaine par Chromatographie sur DEAE Sephadex. Propriétés de la prothrombine purifiée. Coagulation 1969; 1: 258-269
• 8 Pepper DS, Prowse C. Chromatography of human prothrombin complex on Dextran Sulphate Agarose. Thromb Res 1977; 11: 687-692
• 9 Barrowcliffe TW. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis. Thromb Haemostas 1980; 42: 1434-1445
• 10 Thomas DP, Merton RE, Lewis WE, Barrowcliffe TW. Studies in man and experimental animals of a low molecular weight heparin fraction. Thromb Haemostas 1981; 45: 214-218
• 11 Barrowcliffe TW, Eggleton CA. Studies of anti-Xa activity in human plasma. I: Comparison of a fast-acting inhibitor with antithrombin III. Thromb Res 1981; 27: 399-411
• 12 Blix S. Studies on the fibrinolytic system in the euglobulin fraction of human plasma. Scand J Clin Lab Invest 1961; 13 (Suppl. 58) 3-19
• 13 Lindahl U, Bäckström G, Höök M, Thunberg L, Fransson L-A, Linker A. Structure of the antithrombin ID binding site in heparin. Proc Nat Acad Sci USA 1979; 76: 3198-3202
• 14 Ofosu F, Blajchman MA, Hirsh J. The inhibition by heparin of the intrinsic pathway activation of Factor X in the absence of antithrombin III. Thromb Res 1980; 20: 391-403
• 15 Walker FJ, Esmon CT. Interactions between heparin and factor Xa. Inhibition of prothrombin activation. Biochim Biophys Acta 1979; 585: 405-415